Evaluation of Testicular Dose and Associated Risk From Common Pelvis Radiation Therapy in Iran Publisher Pubmed



Shanei A¹ ; Baradaranghahfarokhi M^{1, 2} Show Affiliations
Source: Physica Medica Published:2014

Abstract

This study aimed to investigate testicular dose (TD) and the associated risk of heritable disease from common pelvis radiotherapy of male patients in Iran. In this work, the relation between TD and changes in beam energy, pelvis size, source to skin distance (SSD) and beam directions (anterior or posterior) was also evaluated. The values of TDs were measured on 67 randomly selected male patients during common pelvis radiotherapy using 1.17 and 1.33MeV, Theratron Cobalt-60 unit at SSD of 80cm and 9MV, Neptun 10PC and 18MV, GE Saturne 20 at SSD of 100cm at Seyed-Al Shohada Hospital, Isfahan, Iran. Results showed that, the maximum TD was up to 12% of the tumor dose. Considering the risk factor for radiation-induced heritable disorders of 0.1% per Sv, an excess risk of hereditary disorders of 72 per 10,000 births was conservatively calculated. There was a significant difference in the measured TD using different treatment machines and energies (P<0.001). The Pearson Correlation test showed that, as expected, there was a correlation between TD and patient's pelvis size (r=0.275, P<0.001). Using the student's t-tests, it was found that, there was not a significant difference between TD and beam direction (P=0.231). Iranian male patients undergoing pelvic radiotherapy have the potential of receiving a TD of more than 1Gy which might result in temporary azoospermia. The risk for induction of hereditary disorders in future generations should be considered as low but not negligible in comparison with the correspondent nominal risk. © 2014 Associazione Italiana di Fisica Medica.